Related Experiment Video
Updated: Aug 26, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Multi-component pharmacokinetic study of prunus mume fructus extract after oral administration in rats using
Yameng Zhu1, Shujie Wei1, Xiunan Cao1
1State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Abstract:
Prunus mume fructus (MF) is used in traditional Chinese medicine and food, as it exerts pharmacological effects, such as antibacterial, antioxidant, antitumour, thirst-relieving, and antidiarrheal effects. In the present study, a reliable and sensitive ultra-high performance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS) method was developed and validated for the simultaneous determination of 16 prototype components (L-(-)-malic acid, 3,4-dihydroxybenzaldehyde, protocatechuic acid, vanillic acid, caffeic acid, D-(-)-quinic acid, citric acid, ferulic acid, syringic acid, cryptochlorogenic acid, neochlorogenic acid, chlorogenic acid, amygdalin, maslinic acid, corosolic acid, and rutin) in rat plasma after oral administration of the MF extract. Plasma samples were prepared via protein precipitation using acetonitrile. The 16 components were separated on an ACQUITY UPLC BEH C18 column (2.1 × 100 mm, 1.7 μm) with a gradient mobile phase system of methanol and 0.1% (v/v) formic acid aqueous solution at a flow rate of 0.3 ml/min. All components were quantitated using Agilent Jet Stream electrospray ionisation in negative ion mode. The intra-day and inter-day accuracies ranged from-9.4 to 9.4%, and the precision of the analytes was less than 14.8%. The extraction recovery rate of the analytes ranged from 63.59 to 109.44% and the matrix effects ranged from 49.25 to 109.28%. Stability studies proved that the analytes were stable under the tested conditions, with a relative standard deviation lower than 13.7%. Hence, the developed method was successfully applied to evaluate the pharmacokinetics of 16 components in the MF extract after oral administration in rats using UPLC-MS/MS.
Insights
A new UPLC-MS/MS method quantifies 16 compounds in Prunus mume fructus extract in rat plasma. This validated method enables pharmacokinetic studies of traditional Chinese medicine components.
Area of Science:
- Pharmacology and Traditional Medicine
- Analytical Chemistry
- Pharmacokinetics
Background:
- Prunus mume fructus (MF) is utilized in traditional Chinese medicine and food for its diverse pharmacological properties, including antibacterial, antioxidant, and antidiarrheal effects.
- Understanding the pharmacokinetic profiles of MF's active components is crucial for its medicinal applications.
Purpose of the Study:
- To develop and validate a sensitive ultra-high performance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS) method for the simultaneous determination of 16 key compounds in rat plasma.
- To apply the validated method for evaluating the pharmacokinetics of these 16 components after oral administration of MF extract in rats.
Main Methods:
- A UPLC-MS/MS method was established using an ACQUITY UPLC BEH C18 column with a gradient elution of methanol and formic acid aqueous solution.
- Plasma samples were prepared by protein precipitation with acetonitrile, and analytes were detected using electrospray ionization in negative ion mode.
- Method validation included assessment of accuracy, precision, extraction recovery, matrix effects, and stability.
Main Results:
- The developed UPLC-MS/MS method demonstrated high sensitivity and reliability for quantifying 16 prototype components in rat plasma.
- Intra-day and inter-day accuracies ranged from -9.4% to 9.4%, with precision below 14.8%.
- Extraction recovery, matrix effects, and stability were within acceptable ranges, confirming method robustness.
Conclusions:
- A validated UPLC-MS/MS method provides a reliable tool for analyzing multiple MF components in biological matrices.
- The method facilitates comprehensive pharmacokinetic investigations of Prunus mume fructus extract, supporting its traditional medicinal use.
More Related Videos
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022